350
Participants
Start Date
July 31, 2006
Study Completion Date
December 31, 2006
hepatitis B vaccine
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Hamburg
GSK Investigational Site, Altenholz
GSK Investigational Site, Kiel
GSK Investigational Site, Flensburg
GSK Investigational Site, Flensburg
GSK Investigational Site, Husum
GSK Investigational Site, Bredstedt
GSK Investigational Site, Niebüll
GSK Investigational Site, Marburg/Lahn
GSK Investigational Site, Salzgitter
GSK Investigational Site, Erkrath
GSK Investigational Site, Krefeld
GSK Investigational Site, Willich
GSK Investigational Site, Trier
GSK Investigational Site, Mainz
GSK Investigational Site, Bad Sobernheim
GSK Investigational Site, Schoeneberg - Kuebelberg
GSK Investigational Site, Offenburg
GSK Investigational Site, Kehl
GSK Investigational Site, Oberkirch
GSK Investigational Site, Ettenheim
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Tutzing
GSK Investigational Site, Weilheim
GSK Investigational Site, Erding
GSK Investigational Site, Bobingen
GSK Investigational Site, Aichach
GSK Investigational Site, Nördlingen
GSK Investigational Site, Landsberg am Lech
GSK Investigational Site, Kaufering
GSK Investigational Site, Kempten (Allgäu)
GSK Investigational Site, Pegnitz
GSK Investigational Site, Lohr
GSK Investigational Site, Bischofswerda
GSK Investigational Site, Dresden
GSK Investigational Site, Bad Lobenstein
GSK Investigational Site, Rudolstadt
Lead Sponsor
GlaxoSmithKline
INDUSTRY